Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Attention-deficit/hyperactivity disorder pharmacogenomics.

Biological psychiatry - 1 Jun 2005

McGough James J

Abstract excerpt

Although the efficacy of medications for attention-deficit/hyperactivity disorder (ADHD) is well demonstrated in clinical trials, substantial numbers of patients fail to remain on therapy, and there is tremendous variability in tolerability and treatment acceptance. The emerging science of pharmacogenomics seeks to identify patterns of genetic variation that will direct individually tailored treatment regimens...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention Deficit Disorder with Hyperactivity
Share to Dopamine Agents
Share to Electroencephalography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DBH gene

Share to DRD5 gene

Share to Genetic Variation

Share to Methylphenidate

Share to Pharmacogenetics

Source

Identifiers

PMID: 15950009
DOI: 10.1016/j.biopsych.2004.10.021

Genes

COMT
DBH
DRD4
DRD5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Attention-deficit/hyperactivity disorder pharmacogenomics.PMID 15950009Read ↗

ADHD pharmacogenetics across the life cycle: New findings and perspectivesSemantic proximity Read ↗

Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations.Semantic proximity Read ↗

Pharmacogenetic Approach for a Better Drug Treatment in ChildrenSemantic proximity Read ↗

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.Semantic proximity Read ↗

A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study.Semantic proximity Read ↗

Candidate gene studies of attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate.Semantic proximity Read ↗

Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.Semantic proximity Read ↗

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.